T1	PROC 49 73	estudio de investigación
#1	AnnotatorNotes T1	C0681814; research study; Research Activity
T2	DISO 446 456	mutaciones
#2	AnnotatorNotes T2	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T3	CHEM 111 121	tipifarnib
#3	AnnotatorNotes T3	C1176289; tipifarnib; Organic Chemical · Pharmacologic Substance
T4	DISO 139 179	cáncer de pulmón no microcítico escamoso
T5	ANAT 171 179	escamoso
#4	AnnotatorNotes T5	C0221909; Squamous epithelium; Tissue
T6	PROC 258 269	tratamiento
#5	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	PROC 315 339	Estudio Fase II, abierto
T8	CHEM 363 373	Tipifarnib
#6	AnnotatorNotes T8	C1176289; tipifarnib; Organic Chemical · Pharmacologic Substance
T9	DISO 380 441	cáncer de pulmón avanzado no microcítico de células escamosas
T10	DISO 274 284	mutaciones
#7	AnnotatorNotes T10	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T11	ANAT 424 441	células escamosas
#8	AnnotatorNotes T11	C0221910; Squamous Epithelial Cells; Cell
T12	ANAT 531 539	escamoso
#9	AnnotatorNotes T12	C0221909; Squamous epithelium; Tissue
T13	DISO 598 638	cáncer de pulmón no microcítico escamoso
T14	ANAT 630 638	escamoso
#10	AnnotatorNotes T14	C0221909; Squamous epithelium; Tissue
T15	DISO 713 747	Carcinoma no microcítico de pulmón
T16	DISO 544 552	mutación
T17	ANAT 741 747	pulmón
#11	AnnotatorNotes T17	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T18	PROC 766 799	análisis histológico o citológico
#12	AnnotatorNotes T18	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
T19	PROC 820 827	terapia
#13	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	DISO 865 875	enfermedad
#14	AnnotatorNotes T20	C0012634; Disease; Disease or Syndrome
T21	DISO 877 898	enfermedad progresiva
T22	PROC 930 938	terapias
#15	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	PROC 968 975	terapia
#16	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	PROC 1466 1475	radiación
#17	AnnotatorNotes T24	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T25	PROC 1097 1104	terapia
#18	AnnotatorNotes T25	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T26	DISO 1122 1127	tumor
#19	AnnotatorNotes T26	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T27	DISO 1190 1199	tumorales
#20	AnnotatorNotes T27	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T28	DISO 1221 1228	tumoral
#21	AnnotatorNotes T28	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T29	PROC 1238 1265	evaluación de biomarcadores
T30	DISO 1279 1300	enfermedad mensurable
T31	PROC 1366 1383	terapia sistémica
#22	AnnotatorNotes T31	C1515119; Systemic Therapy; Therapeutic or Preventive Procedure
T32	PROC 1446 1458	radioterapia
#23	AnnotatorNotes T32	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T33	DISO 1515 1536	enfermedad mensurable
T34	DISO 1575 1602	progresión de la enfermedad
#24	AnnotatorNotes T34	C0242656; Disease Progression; Pathologic Function
T35	DISO 1678 1689	toxicidades
#25	AnnotatorNotes T35	C0600688; Toxic effect; Injury or Poisoning
T36	PROC 1696 1708	radioterapia
#26	AnnotatorNotes T36	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T37	DISO 1775 1798	Enfermedad concomitante
T38	ANAT 519 530	microcítico
#27	AnnotatorNotes T38	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T39	ANAT 509 515	pulmón
#28	AnnotatorNotes T39	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T40	PROC 2178 2187	protocolo
#29	AnnotatorNotes T40	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T41	PROC 2109 2133	consentimiento informado
#30	AnnotatorNotes T41	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T42	PROC 1615 1624	irradiado
#31	AnnotatorNotes T42	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T43	PROC 2241 2250	protocolo
#32	AnnotatorNotes T43	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T44	ANAT 149 155	pulmón
#33	AnnotatorNotes T44	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T45	ANAT 159 170	microcítico
#34	AnnotatorNotes T45	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T46	DISO 214 225	metastásico
#35	AnnotatorNotes T46	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T47	PROC 348 359	tratamiento
#36	AnnotatorNotes T47	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T48	ANAT 390 396	pulmón
#37	AnnotatorNotes T48	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T49	ANAT 409 420	microcítico
#38	AnnotatorNotes T49	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T50	ANAT 608 614	pulmón
#39	AnnotatorNotes T50	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T51	ANAT 618 629	microcítico
#40	AnnotatorNotes T51	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T52	DISO 673 684	metastásico
#41	AnnotatorNotes T52	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T53	ANAT 726 737	microcítico
#42	AnnotatorNotes T53	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T54	DISO 1132 1140	mutación
T55	DISO 499 539	cáncer de pulmón no microcítico escamoso
T56	ANAT 1214 1228	tejido tumoral
T57	DISO 2018 2059	Estado mental significativamente alterado
T58	PROC 1149 1163	Consentimiento
#43	AnnotatorNotes T58	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T59	Date 13 17	2017
T60	LIVB 125 134	pacientes
#44	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Neg_cue 156 158	no
T62	Neg_cue 406 408	no
T63	LIVB 485 494	Pacientes
#45	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	Neg_cue 516 518	no
T65	LIVB 584 593	Pacientes
#46	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	Neg_cue 615 617	no
T67	Neg_cue 723 725	no
T68	Neg_cue 813 815	no
T69	Duration 1066 1078	los 12 meses
T70	Duration 1331 1349	Al menos 2 semanas
T71	Duration 1411 1429	Al menos 2 semanas
T73	LIVB 1630 1637	sujetos
#47	AnnotatorNotes T73	C0681850; Study Subject; Group
T74	PHYS 1654 1664	recuperado
#48	AnnotatorNotes T74	C2004454; Recovery - healing process; Organism Function
T75	LIVB 1885 1897	investigador
#49	AnnotatorNotes T75	C0035173; Research Personnel; Professional or Occupational Group
T77	LIVB 1932 1938	sujeto
#50	AnnotatorNotes T77	C0681850; Study Subject; Group
T78	LIVB 1954 1960	Sujeto
#51	AnnotatorNotes T78	C0681850; Study Subject; Group
T80	PHYS 2025 2031	mental
#52	AnnotatorNotes T80	C0229992; Psyche structure; Mental Process
T81	PHYS 2077 2088	comprensión
#53	AnnotatorNotes T81	C0162340; Comprehension; Mental Process
T85	GENE 457 461	HRAS
#54	AnnotatorNotes T85	C0079471; HRAS gene; Gene or Genome
T86	GENE 553 557	HRAS
#55	AnnotatorNotes T86	C0079471; HRAS gene; Gene or Genome
T87	GENE 1141 1145	HRAS
#56	AnnotatorNotes T87	C0079471; HRAS gene; Gene or Genome
T72	GENE 288 292	HRAS
#57	AnnotatorNotes T72	C0079471; HRAS gene; Gene or Genome
T76	DISO 851 858	Recaída
#58	AnnotatorNotes T76	C0699753; Cancer Relapse; Neoplastic Process
T79	DISO 1028 1035	recaída
#59	AnnotatorNotes T79	C0699753; Cancer Relapse; Neoplastic Process
A1	Assertion T45 Negated
A2	Assertion T38 Negated
A3	Assertion T51 Negated
A4	Assertion T53 Negated
A5	Assertion T19 Negated
A6	Status T22 History_of
A7	Status T23 History_of
A8	Status T25 History_of
A9	Status T31 History_of
A10	Status T32 History_of
#60	AnnotatorNotes T4	C4509816; Squamous non-small cell lung cancer; Neoplastic Process
#61	AnnotatorNotes T55	C4509816; Squamous non-small cell lung cancer; Neoplastic Process
#62	AnnotatorNotes T13	C4509816; Squamous non-small cell lung cancer; Neoplastic Process
#63	AnnotatorNotes T15	C4509816; Squamous non-small cell lung cancer; Neoplastic Process
#64	AnnotatorNotes T9	C4727782; Advanced Lung Non-Small Cell Squamous Carcinoma; Neoplastic Process 
#65	AnnotatorNotes T7	C0282460; Phase 2 Clinical Trials; Research Activity + C1709323; Open Label Study; Research Activity 
#66	AnnotatorNotes T16	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#67	AnnotatorNotes T21	C1335499; Progressive Disease; Disease or Syndrome 
#68	AnnotatorNotes T54	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#69	AnnotatorNotes T56	C0475358; Tumor tissue sample; Tissue
#70	AnnotatorNotes T29	C1879847; Biomarker Analysis; Laboratory Procedure
#71	AnnotatorNotes T30	C1513041; Measurable Disease; Disease or Syndrome
#72	AnnotatorNotes T33	C1513041; Measurable Disease; Disease or Syndrome
#73	AnnotatorNotes T37	C0243087; concomitant disease; Pathologic Function
T82	Spec_cue 1815 1821	podría
T83	Spec_cue 1899 1905	podría
T84	CONC 1822 1832	interferir
A11	Assertion T84 Speculated
#74	AnnotatorNotes T84	C0521102; Interferes with; Functional Concept
T88	Observation 1917 1923	riesgo
A12	Assertion T88 Speculated
T89	Neg_cue 2189 2197	Falta de
T90	Neg_cue 2209 2225	incapacidad para
T91	Observation 2226 2250	cumplir con el protocolo
A13	Assertion T91 Negated
#75	AnnotatorNotes T91	C2364172; Adherence To Medication Regime; Finding (?)
T92	Observation 2198 2206	voluntad
A14	Assertion T92 Negated
#76	AnnotatorNotes T92	C0600109; Willing; Finding
T93	Quantifier_or_Qualifier 828 836	curativa
A15	Assertion T93 Negated
R1	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T93	
R2	Negation Arg1:T68 Arg2:T19	
R3	Negation Arg1:T68 Arg2:T93	
R4	Negation Arg1:T89 Arg2:T92	
R5	Negation Arg1:T90 Arg2:T91	
R6	Speculation Arg1:T82 Arg2:T84	
R7	Speculation Arg1:T83 Arg2:T88	
T94	Spec_cue 2064 2073	limitaría
A16	Assertion T81 Speculated
R8	Speculation Arg1:T94 Arg2:T81	
A17	Assertion T41 Speculated
R9	Speculation Arg1:T94 Arg2:T41	
T95	Observation 2139 2169	cumplimiento de los requisitos
A18	Assertion T95 Speculated
R10	Speculation Arg1:T94 Arg2:T95	
T96	Observation 98 107	respuesta
#77	AnnotatorNotes T96	C1319171; Medication response; Finding
R11	Overlap Arg1:T96 Arg2:T3	
R12	Experiences Arg1:T60 Arg2:T96	
R13	Experiences Arg1:T60 Arg2:T3	
R14	Experiences Arg1:T60 Arg2:T4	
R15	Negation Arg1:T61 Arg2:T45	
R16	Location_of Arg1:T44 Arg2:T4	
R17	Location_of Arg1:T5 Arg2:T4	
T97	Quantifier_or_Qualifier 180 199	localmente avanzado
R18	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T97	
T98	Observation 200 211	irresecable
#78	AnnotatorNotes T98	C4039777; Tumor surgically unresectable; Finding
R19	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T98	
T99	Observation 659 670	irresecable
#79	AnnotatorNotes T99	C4039777; Tumor surgically unresectable; Finding
R20	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T99	
R21	Before Arg1:T13 Arg2:T52	
R22	Before Arg1:T4 Arg2:T46	
A19	Assertion T49 Negated
R23	Negation Arg1:T62 Arg2:T49	
R24	Location_of Arg1:T48 Arg2:T9	
R25	Location_of Arg1:T11 Arg2:T9	
R26	Location_of Arg1:T12 Arg2:T55	
R27	Negation Arg1:T64 Arg2:T38	
R28	Location_of Arg1:T39 Arg2:T55	
R29	Experiences Arg1:T63 Arg2:T55	
R30	Experiences Arg1:T63 Arg2:T16	
R31	Overlap Arg1:T55 Arg2:T16	
R32	Location_of Arg1:T86 Arg2:T16	
R33	Location_of Arg1:T72 Arg2:T10	
R34	Overlap Arg1:T4 Arg2:T10	
R35	Experiences Arg1:T60 Arg2:T46	
R36	Experiences Arg1:T60 Arg2:T10	
R37	Used_for Arg1:T8 Arg2:T47	
R38	Overlap Arg1:T9 Arg2:T2	
R39	Location_of Arg1:T85 Arg2:T2	
T100	Observation 227 238	recidivante
#80	AnnotatorNotes T100	C2825055; Recurrence (disease attribute); Pathologic Function
R40	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T100	
T101	Observation 243 269	refractario al tratamiento
#81	AnnotatorNotes T101	C0438286; Absent response to treatment; Finding
R41	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T101	
T102	Quantifier_or_Qualifier 639 658	localmente avanzado
R42	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T102	
R43	Experiences Arg1:T65 Arg2:T13	
R44	Experiences Arg1:T65 Arg2:T52	
R45	Negation Arg1:T66 Arg2:T51	
R46	Location_of Arg1:T50 Arg2:T13	
R47	Location_of Arg1:T14 Arg2:T13	
R48	Negation Arg1:T67 Arg2:T53	
R49	Location_of Arg1:T17 Arg2:T15	
R51	Before Arg1:T20 Arg2:T76	
T103	Observation 906 917	refractario
#82	AnnotatorNotes T103	C0438286; Absent response to treatment; Finding
T104	Quantifier_or_Qualifier 920 929	una o más
R52	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T104	
R53	Overlap Arg1:T103 Arg2:T22	
R54	Overlap Arg1:T20 Arg2:T103	
R55	Overlap Arg1:T79 Arg2:T69	
R56	Before Arg1:T25 Arg2:T79	
R57	Before Arg1:T23 Arg2:T79	
R58	Before Arg1:T22 Arg2:T76	
R59	Overlap Arg1:T101 Arg2:T6	
R60	Experiences Arg1:T60 Arg2:T101	
R61	Overlap Arg1:T26 Arg2:T54	
R62	Location_of Arg1:T87 Arg2:T54	
R63	Location_of Arg1:T56 Arg2:T29	
R66	Before Arg1:T58 Arg2:T29	
T105	CONC 1316 1327	RECIST v1.1
#83	AnnotatorNotes T105	C1709926; Response Evaluation Criteria in Solid Tumors; Intellectual Product
R67	Before Arg1:T31 Arg2:T70	
T106	PROC 1396 1407	inscripción
#84	AnnotatorNotes T106	C4041024; Enrollment in clinical trial; Research Activity
R68	Before Arg1:T31 Arg2:T106	
R69	Before Arg1:T32 Arg2:T71	
T107	Quantifier_or_Qualifier 1480 1490	localizada
#85	AnnotatorNotes T107	C0392752; Localized; Spatial Concept
R70	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T107	
R72	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T107	
T108	CONC 1552 1565	documentación
#86	AnnotatorNotes T108	C0920316; Documentation; Intellectual Product
R74	Experiences Arg1:T73 Arg2:T74	
R75	Before Arg1:T35 Arg2:T74	
R76	Causes Arg1:T36 Arg2:T35	
R77	Experiences Arg1:T73 Arg2:T35	
R78	Experiences Arg1:T73 Arg2:T36	
T109	CONC 1732 1736	ECOG
#87	AnnotatorNotes T109	C1520224; ECOG performance status; Intellectual Product
T110	Result_or_Value 1740 1745	0 o 1
R79	Has_Result_or_Value Arg1:T109 Arg2:T110	
T111	PROC 1855 1862	estudio
#88	AnnotatorNotes T111	C0008976; Clinical Trials; Research Activity
R81	Before Arg1:T37 Arg2:T88	
R82	Experiences Arg1:T77 Arg2:T37	
R83	Experiences Arg1:T77 Arg2:T88	
T112	Observation 1961 1984	incapacitado legalmente
R84	Has_Quantifier_or_Qualifier Arg1:T78 Arg2:T112	
T113	Observation 1993 2014	limitada su capacidad
R85	Experiences Arg1:T78 Arg2:T113	
#89	AnnotatorNotes T57	C4062794; Alteration in mental status; Mental or Behavioral Dysfunction (?)
R87	Before Arg1:T57 Arg2:T81	
R90	Before Arg1:T57 Arg2:T95	
R91	Overlap Arg1:T92 Arg2:T43	
R92	Overlap Arg1:T91 Arg2:T43	
R93	Overlap Arg1:T76 Arg2:T21	
T114	Quantifier_or_Qualifier 999 1008	adyuvante
#90	AnnotatorNotes T114	C1522673; Adjuvant; Functional Concept
R94	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T114	
T115	Quantifier_or_Qualifier 1011 1023	neoadyuvante
R95	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T115	
R98	Overlap Arg1:T81 Arg2:T41	
#91	AnnotatorNotes T88	C0559571; At risk; Finding
R99	Experiences Arg1:T60 Arg2:T6	
#92	AnnotatorNotes T93	C1880198; Cure (remedy); Conceptual Entity (?)
A20	Experiencer T60 Patient
A21	Experiencer T63 Patient
A22	Experiencer T65 Patient
A23	Assertion T24 Hypothetical
A24	Assertion T107 Hypothetical
A25	Assertion T33 Hypothetical
A26	Experiencer T75 Other
A27	Experiencer T77 Patient
A28	Experiencer T78 Patient
A29	Experiencer T73 Patient
